MigraineMind research summary
Burden of Migraine in the United States
Archives of Internal Medicine | 1999
Observational studySummary
Migraine is a common and disabling condition with significant economic impacts. This study estimated the burden of migraine in the United States. Researchers analyzed data from multiple sources, including published studies and medical claims data. They measured disability in terms of bedridden days per year. Men required about 3.8 bedridden days, while women needed 5.6 days. This totals around 112 million bedridden days annually. Migraine costs American employers approximately $13 billion yearly due to lost workdays. About $8 billion of this is directly from missed work. Patients aged 30 to 49 years face higher indirect costs than other age groups. Direct medical costs for migraine care are around $1 billion each year. Each diagnosed patient costs about $100 annually for care. Most costs arise from physician office visits, while emergency department visits contribute less than 1%. Effective screening and treatment options are needed to lessen this burden. Clinical relevance: This research highlights the significant economic impact of migraine on patients and employers, emphasizing the need for effective management strategies to reduce lost productivity and healthcare costs.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.
